LifeStance Health Group, Inc. provided earnings guidance for the third quarter of 2023. For the third quarter of 2023, the company expects total revenue of $250 million to $260 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.265 USD | -0.47% | -2.91% | -32.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.79% | 2.02B | |
+24.34% | 89.22B | |
-22.68% | 76.59B | |
+3.24% | 26.87B | |
-9.00% | 17.41B | |
+1.00% | 17.25B | |
-0.15% | 15.25B | |
+80.37% | 13.43B | |
+71.98% | 13.26B | |
-24.74% | 13.22B |
- Stock Market
- Equities
- LFST Stock
- News LifeStance Health Group, Inc.
- LifeStance Health Group, Inc. Provides Earnings Guidance for the Third Quarter of 2023